LifeScan Collaborates with i-SENS to Launch OneTouch Continuous Glucose Monitoring System
Published: 20 Feb 2026
Author: Precedence Research
LifeScan recently made a huge announcement about a partnership with i-SENS to launch a new OneTouch continuous glucose monitoring system. This new system is a result of LifeScan’s efforts to move beyond the boundaries of blood glucose monitoring. The company now wants to provide innovative solutions for real-time monitoring of glucose levels.
The OneTouch continuous glucose monitoring system is expected to track glucose levels continuously. The system will not require frequent fingerstick tests. This product will be able to provide users with real-time glucose levels, which will enable them to make quick and informed decisions about their health. This partnership between LifeScan and i-SENS will help LifeScan leverage its global presence in glucose monitoring. On the other hand, i-SENS has experience in developing accurate and reliable diagnostic products. The collaboration will help both companies accelerate the development of innovative products.
This emerging CGM solution is expected to be integrated with digital platforms. This will enable users to monitor trends, share information with healthcare professionals and gain personalized insights. This integration will facilitate better long term management of diseases and patient engagement. The OneTouch CGM system has emerged at a time when the demand for continuous monitoring systems is growing rapidly. Patients and healthcare professionals are increasingly turning to solutions that provide convenience, accuracy and connectivity. This product is set to compete in this rapidly growing market.
This development marks the beginning of a new era for LifeScan’s product development. It marks the company’s focus on next-generation diabetes care solutions. With this launch, both companies are set to enhnce their presence in the global CGM market.
We focus exclusively on this industry and provide insights that help you make better decisions. Get in touch to learn more@ https://www.precedenceresearch.com/biosensors-market